Source link : https://www.newshealth.biz/health-news/liraglutide-reduces-bmi-by-almost-6-in-children-aged-6-to-12/
The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the phase 3a SCALE-KIDS trial presented at the European Association for the Study of Diabetes (EASD) 2024 Annual Meeting and simultaneously published in the New England Journal of Medicine. After […]
Author : News Health
Publish date : 2024-09-11 15:53:26
Copyright for syndicated content belongs to the linked Source.
Categories